BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 17630499)

  • 1. Development, reliability and validity of a self-administered questionnaire on subjective opinion about delusions and voices.
    Pinto A; Gigantesco A; Morosini P; La Pia S
    Psychopathology; 2007; 40(5):312-20. PubMed ID: 17630499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The voices acceptance and action scale (VAAS): Pilot data.
    Shawyer F; Ratcliff K; Mackinnon A; Farhall J; Hayes SC; Copolov D
    J Clin Psychol; 2007 Jun; 63(6):593-606. PubMed ID: 17457846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of a self-report questionnaire measuring auditory verbal hallucinations.
    Kim SH; Jung HY; Hwang SS; Chang JS; Kim Y; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):968-73. PubMed ID: 20472012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring ideas of persecution and social reference: the Green et al. Paranoid Thought Scales (GPTS).
    Green CE; Freeman D; Kuipers E; Bebbington P; Fowler D; Dunn G; Garety PA
    Psychol Med; 2008 Jan; 38(1):101-11. PubMed ID: 17903336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brief measure to assess perception of self-influence on the disease course. Version for schizophrenia].
    Kokoszka A; Telichowska-Leśna A; Radzio R
    Psychiatr Pol; 2008; 42(4):503-13. PubMed ID: 19189595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical dimensions of auditory hallucinations in schizophrenic disorders.
    Oulis P; Gournellis R; Konstantakopoulos G; Matsoukas T; Michalopoulou PG; Soldatos C; Lykouras L
    Compr Psychiatry; 2007; 48(4):337-42. PubMed ID: 17560954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief psychoeducation for schizophrenia primarily intended to change the cognition of auditory hallucinations: an exploratory study.
    Shiraishi N; Watanabe N; Kinoshita Y; Kaneko A; Yoshida S; Furukawa TA; Akechi T
    J Nerv Ment Dis; 2014 Jan; 202(1):35-9. PubMed ID: 24375210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation and psychosis in dissociative identity disorder and schizophrenia.
    Laddis A; Dell PF
    J Trauma Dissociation; 2012; 13(4):397-413. PubMed ID: 22651674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three assessment tools for deliberate self-harm and suicide behavior: evaluation and psychopathological correlates.
    Fliege H; Kocalevent RD; Walter OB; Beck S; Gratz KL; Gutierrez PM; Klapp BF
    J Psychosom Res; 2006 Jul; 61(1):113-21. PubMed ID: 16813853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimensions of delusional experience scale: a psychometric evaluation of a german version.
    Büche L; Gentner NC; Kaiser S; von Bock A; Grupe S; Joest K; Barthel A; Vedder H; Mundt C; Kronmüller KT
    Psychopathology; 2010; 43(3):189-96. PubMed ID: 20375541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On two kinds of delusion of reference.
    Startup M; Startup S
    Psychiatry Res; 2005 Nov; 137(1-2):87-92. PubMed ID: 16226316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The criterion and discriminant validity of the Referential Thinking (REF) scale.
    Startup M; Sakrouge R; Mason OJ
    Psychol Assess; 2010 Mar; 22(1):65-9. PubMed ID: 20230153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.
    Balestrieri M; Giaroli G; Mazzi M; Bellantuono C
    Pharmacopsychiatry; 2006 May; 39(3):81-4. PubMed ID: 16721695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.
    Selten JP; Wiersma D; van den Bosch RJ
    Compr Psychiatry; 2000; 41(3):191-6. PubMed ID: 10834628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis.
    Drake R; Haddock G; Tarrier N; Bentall R; Lewis S
    Schizophr Res; 2007 Jan; 89(1-3):119-22. PubMed ID: 17095193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Befriending patients with medication-resistant schizophrenia: can psychotic symptoms predict treatment response?
    Samarasekera N; Kingdon D; Siddle R; O'Carroll M; Scott JL; Sensky T; Barnes TR; Turkington D
    Psychol Psychother; 2007 Mar; 80(Pt 1):97-106. PubMed ID: 17346383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subjective view of positive symptoms and quality of life in patients with schizophrenia].
    Karow A; Schäfer I; Hirdes F; Osterwald C; Naber D
    Psychiatr Prax; 2008 Sep; 35(6):286-93. PubMed ID: 18504688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brown Assessment of Beliefs Scale: reliability and validity.
    Eisen JL; Phillips KA; Baer L; Beer DA; Atala KD; Rasmussen SA
    Am J Psychiatry; 1998 Jan; 155(1):102-8. PubMed ID: 9433346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.